Velosef (Cefaclor) in Pregnancy: Safety Profile & Prescribing Guidance
Velosef (cefaclor) is a second-generation cephalosporin antibiotic. It is FDA Pregnancy Category B (animal studies show no fetal risk; no adequate human studies).
Safety Summary
- Widely used in pregnancy for UTIs, respiratory, skin/soft tissue infections.
- No consistent pattern of congenital anomalies in surveillance data.
- Crosses placenta but fetal levels low; no teratogenicity demonstrated.
Precautions & Contraindications
- Allergy: Avoid if history of cephalosporin or severe penicillin allergy (≈1–2% cross-reactivity).
- Renal impairment: Dose adjust (CrCl <30 mL/min).
- Late pregnancy: Theoretical risk of neonatal bleeding (cephamycins inhibit platelet aggregation); cefaclor less implicated but some clinicians avoid near term.
- Pseudomembranous colitis: C. difficile risk with any antibiotic.
Prescribing Principles
- Use only for confirmed/suspected bacterial infection.
- Choose narrowest spectrum effective agent.
- Shortest effective duration.
- Discuss risks/benefits with patient; document.
Alternatives (if allergy/intolerance): penicillins (amoxicillin), macrolides (azithromycin), fosfomycin (UTI). Always culture when feasible.
Pregnancy & Health - Related Articles
- Pregnancy Announcement Songs: 10 Heartfelt Ideas Across Genres
- Coriander (Cilantro) During Pregnancy: Safety, Benefits & Precautions
- Confirming Pregnancy: Methods and What to Expect
- Earliest Pregnancy Detection: Blood Test at 10 Days Post‑Ovulation vs. Home Tests
- Urine Tests for Fetal Sex: Not Scientifically Valid
- Bloating With Negative Pregnancy Tests: 10 Common Causes and Solutions
- Uterus Size vs. Gestational Age: Understanding Discrepancies
